Case reports of rhino-orbital mucor mycosis following dengue and typhoid, from a tertiary care institute
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20222041Keywords:
Mucor mycosis, Dengue fever, Delivery of health care, Fungal infectionAbstract
Mucor mycosis is a highly invasive and progressive opportunistic infection with higher rates of morbidity and mortality. It is attributed to compromised immunity status of individuals with poor oral and nasal hygiene. It got rapidly progressed and become a visible threat to the life among the delayed diagnosed cases. Therefore, new threats and pathogenesis are required to understand the prevention and treatment of the disease. Dengue is the most common arthropod born viral disease but unfortunately no effective antiviral treatment is available till now. Two case reports were done to illustrates the pathway of Mucor mycosis in dengue and typhoid infection, admitted at Tertiary Care hospital of Jabalpur District. Data was collected through interview with the case and care taker and case file review. These were the case of rhino- orbital Mucor mycosis attributed to compromised immunity during the treatment of respective infection. The early diagnosis, prompt Treatment with necessary surgical intervention are the essential steps to slow down the disease progression as well as successful outcome.
References
Suganya R, Malathi N, Karthikeyan V, Janagaraj VD. Mucormycosis: A Brief Review. J Pure Appl Microbiol. 2019;13(1):161-5.
Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi (Basel). 2019;5(1):26.
Afroze SN, Korlepara R, Rao GV, Madala J. Mucormycosis in a Diabetic Patient: A Case Report with an Insight into Its Pathophysiology. Contemp Clin Dent. 2017;8(4):662-6.
Sabobeh T, Mushtaq K, Elsotouhy A, Ammar AA, Rashid S. Invasive rhino cerebral mucormycosis in a patient with liver cirrhosis leading to fatal massive stroke. Med Mycol Case Rep. 2018;22:69-73.
Mulakavalupil B, Vaity C, Joshi S, Misra A, Pandit RA. Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit. Diabetes Metab Syndr. 2021;15(4):102169.
